Anticorps Monoclonal anti-ITM2C

ITM2C Monoclonal Antibody for IF/ICC

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

canin, Humain

Applications

IF/ICC

Conjugaison

CoraLite®594 Fluorescent Dye

CloneNo.

2E8G11

N° de cat : CL594-60095

Synonymes

E25, CT-BRI3, Cerebral protein 14, BRICD2C, BRI3



Applications testées

Résultats positifs en IF/ICCcellules HepG2, cellules MDCK

Dilution recommandée

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

CL594-60095 cible ITM2C dans les applications de IF/ICC et montre une réactivité avec des échantillons canin, Humain

Réactivité canin, Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène ITM2C Protéine recombinante Ag4409
Nom complet integral membrane protein 2C
Masse moléculaire calculée230aa,26 kDa; 267aa,30 kDa
Poids moléculaire observé 35 kDa
Numéro d’acquisition GenBankBC025742
Symbole du gène ITM2C
Identification du gène (NCBI) 81618
Conjugaison CoraLite®594 Fluorescent Dye
Excitation/Emission maxima wavelengths588 nm / 604 nm
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA
Conditions de stockageStocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

The Integral membrane protein 2C (ITM2C) is a type II integral transmembrane protein belonging to a family composed of at least two other members, ITM2A and ITM2B. ITM2C, often called transmembrane protein BRI3, is highly expressed in brain tissue. Yeast two-hybrid screen system revealed that BRI3 could interact with beta-secretase beta-amyloid protein converting enzyme (BACE)1 and the microtubule-destabilizing protein SCG10 (STMN2). It may play a role in TNF-induced cell death and neuronal differentiation. BRI3 was found to inhibit the various processing of amyloid precursor protein (APP) by blocking the access of alpha- and beta-secretases to APP, competitive inhibition of APP processing by BRI3 may provide a new approach to Alzheimer disease (AD) therapy and prevention.

Protocole

Product Specific Protocols
IF protocol for CL594 ITM2C antibody CL594-60095Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}